The latest molecular studies have offered several insights in to the procedures that govern the development and progression of CLL, including lots of novel mutated genes clustered in numerous functional pathways. The CLL epigenome is reprogrammed in the modulation of regulatory locations that surface de novoIn addition, some genes appear to be part